Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.9T | 2.0T | 1.4T | 2.1T |
Cost of revenue | 1.7T | 1.8T | 1.3T | 1.9T |
Gross profit | 165.1B | 173.0B | 146.3B | 196.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 32.2B | 31.4B | 26.7B | 30.8B |
Other operating expenses | 6.1B | 1.9B | 8.4B | 7.3B |
Operating income | 101.2B | 109.7B | 79.9B | 124.2B |
Non operating interest income | ||||
Income | 4.1B | 3.1B | 3.3B | 2.9B |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 116.1B | 120.8B | 46.5B | 139.9B |
Tax provision | 26.2B | 27.8B | 18.7B | 26.0B |
Net income | 90.0B | 93.0B | 27.8B | 113.9B |
Basic EPS | — | 113 | — | — |
Diluted EPS | — | 113 | — | — |
Basic average shares | — | 822.3M | — | — |
Diluted average shares | — | 822.3M | — | — |
EBITDA | 102.4B | 110.8B | 118.1B | 125.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -209.9M | -184.3M | -99.3M | -83.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |